T. Rowe Price (BRKR holder) discloses 3.0% Bruker Corp stake in 13G/A

Rhea-AI Filing Summary

T. Rowe Price Investment Management, Inc. filed an amended Schedule 13G/A reporting its beneficial ownership of 4,594,398 shares of Bruker Corp common stock, representing 3.0% of the class as of 12/31/2025. The firm has sole voting power over 4,584,656 shares and sole dispositive power over 4,594,398 shares, with no shared voting or dispositive power. The filing states the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Bruker. The filer also affirms that this should not be construed as an admission of beneficial ownership, which is expressly denied.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 6)

BRUKER CORP

(Name of Issuer)

COMMON STOCK

(Title of Class of Securities)

116794108

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 116794108

1

Names of Reporting Persons

T. Rowe Price Investment Management, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

MARYLAND

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 4,584,656.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 4,594,398.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,594,398.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

3.0 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: BRUKER CORP
(b)	Address of issuer's principal executive offices: 40 MANNING RD, BILLERICA, MA, 1821
Item 2.
(a)	Name of person filing: T. Rowe Price Investment Management, Inc.
(b)	Address or principal business office or, if none, residence: 1307 Point Street, Baltimore, MD 21231
(c)	Citizenship: Maryland
(d)	Title of class of securities: COMMON STOCK
(e)	CUSIP No.: 116794108
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 4594398
(b)	Percent of class: 3.0 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 4584656
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 4594398
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. T. Rowe Price Investment Management, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Investment Management is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

T. Rowe Price Investment Management, Inc.

Signature:	Ellen York
Name/Title:	Vice President
Date:	02/17/2026

FAQ

What stake in Bruker Corp (BRKR) does T. Rowe Price report in this filing?

T. Rowe Price Investment Management reports beneficial ownership of 4,594,398 Bruker Corp common shares, representing 3.0% of the outstanding class as of December 31, 2025. This reflects a sub‑5% institutional position under Schedule 13G/A reporting.

What voting and dispositive powers does T. Rowe Price have over BRKR shares?

T. Rowe Price reports sole voting power over 4,584,656 Bruker shares and sole dispositive power over 4,594,398 shares. It reports no shared voting or dispositive power, indicating decisions are controlled solely by the reporting entity for these shares.

Why is Bruker Corp’s Schedule 13G/A with T. Rowe Price significant for investors?

The filing shows T. Rowe Price holds a 3.0% institutional stake in Bruker, below the 5% threshold. It confirms the position is held in the ordinary course of business and not with the purpose of influencing control, signaling a typical investment holding.

Does T. Rowe Price intend to influence control of Bruker Corp (BRKR)?

The filing states the securities were acquired and are held in the ordinary course of business and not for changing or influencing control of Bruker. It also notes the shares are not held in connection with any transaction having that purpose or effect.

What does the 5 percent or less disclosure mean in this Bruker 13G/A?

Item 5 confirms T. Rowe Price’s Bruker position represents 5 percent or less of the class. This indicates the firm is below the higher 5% reporting threshold associated with larger beneficial owners and is reporting under Schedule 13G as a smaller institutional holder.

Who signed the Bruker Corp (BRKR) Schedule 13G/A on behalf of T. Rowe Price?

The Schedule 13G/A was signed by Ellen York, identified as a Vice President of T. Rowe Price Investment Management, Inc. The signature block includes a certification that the information provided is true, complete, and correct to the best of her knowledge and belief.